Beamtree Holdings Ltd (BMT) Stock Price & News

Beamtree is a health data analytics company based in Sydney, Australia. Tim Kelsey was appointed chief executive in December 2020. Mark Britnell was appointed chair of the Beamtree Global Impact Committee in August 2021. An international division was launched in the UK in 2021. The company funds an Associate Professor of Clinical Informatics and Data Science at the University of Sydney. Wikipedia

About Beamtree Holdings Ltd

CEOTim Kelsey

Employees93

Founded1996

Headquarters-

SectorHealth Care

Industry-

Websitebeamtree.com.au

All values in AUD	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	7,27 m	7,27 m	7,33 m	7,33 m
Cost of goods sold	6,18 m	6,18 m	6,41 m	6,41 m
Cost of revenue	6,18 m	6,18 m	6,41 m	6,41 m
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	526,00 k	526,00 k	410,00 k	410,00 k
Operating expense	2,72 m	2,72 m	1,73 m	1,73 m
Total operating expenses	8,90 m	8,90 m	8,13 m	8,13 m
Operating income	-1,63 m	-1,63 m	-804,50 k	-804,50 k
Other non operating income	-	-	-	-
EBT including unusual items	-1,66 m	-1,66 m	-7,43 m	-7,43 m
EBT excluding unusual items	-1,66 m	-1,66 m	-865,00 k	-865,00 k
Income tax expense	-230,50 k	-230,50 k	273,50 k	273,50 k
Effective tax rate	13,85%	13,85%	-3,68%	-3,68%
Other operating expenses	580,50 k	580,50 k	550,50 k	550,50 k
Net income	-1,43 m	-1,43 m	-7,70 m	-7,70 m
Net profit margin	-19,73%	-19,73%	-105,09%	-105,09%
Earnings per share	-	-	-	-
Interest and investment income	26,00 k	26,00 k	500,00	500,00
Interest expense	-58,50 k	-58,50 k	-61,00 k	-61,00 k
Net interest expenses	-32,50 k	-32,50 k	-60,50 k	-60,50 k
Depreciation and amortization charges	1,40 m	1,40 m	1,16 m	1,16 m
EBITDA	-227,00 k	-227,00 k	-72,67 k	-409,00 k
Gain or loss from assets sale	-	-	-	-

Ask anything